For decades, ecologists have known that how a species looks or eats affects its environment. But a new study by researchers at the University of California, Santa Cruz, shows that social behavior ...

Ph.D. student Zarluis Mijango Ramos reveals some of the bizarre and specialized adaptations plants have developed to allow them to grow in most environments around the globe. Plants are fascinating ...

We conducted a serial cross-sectional study to evaluate the use of PET imaging among commercial insurance beneficiaries with prostate cancer using administrative claims from deidentified Blue Cross ...

Abstract: In this paper, we aim to enhance the generalization ability of single-shot face anti-spoofing tasks in two aspects: 1) we establish a deep frequency factorization network (DFF-Net) to ...

Along with “Variation” and “Fourth Wing,” other Yarros book-to-screen adaptations currently in the works include “In the Likely Event” movie at Netflix and “The Last Letter” as a film from Amazon MGM.

People can think, behave and function very differently. These observed differences are known to be the result of complex interactions between genetics, neurobiological processes and life experiences.

Researchers at Princeton University and the Simons Foundation have identified four clinically and biologically distinct subtypes of autism, marking a transformative step in understanding the condition ...

Species are often identified by gaps in their morphological and genetic diversity. However, the levels of differences that are typically observed between closely related species can also be observed ...

The purchase will allow Johnson & Johnson to delve further into the treatment of central nervous system disorders. The purchase is one of several transactions in recent years to boost its ...

J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for $14.6 billion, boosting its presence in the market for neurological disorder treatments. J&J will buy all of ...